Home › Core › ISCC-IDs › 28CrZjQ381b1Y

View ISCC-ID

Core Data

28CrZjQ381b1Y
ISCC-ID - digital asset identifier
CCc2NpTvjjAt1-CThn8PpupBXcb-CDXdvxRDS65Ls-CR9A7GYULew2C
ISCC-CODE - digital asset descriptor
2QTa5N4aeSrCB2MLoPdPF4AsTjstJgcLTnd
PUBLIC-KEY or WALLET-ADDRESS of DECLARING PARTY
0
Number of times updated

Seed Metadata (Immutable)

human interferoninducible protein 10 is a potent inhibitor of angiogenesis in vivo

Ledger Reference

coblo
Source Ledger/Blockchain
664706
N-th ISCC Decleration on source ledger
3e07c8492d37b175de65c12900a69712221041f1153911695aae3fbb02ca3a9f
Hash of block that includes the ISCC-DECLARATION
a53541e9ad4a00fbba322b0f174615ee2815d404853a2033121222da854954cf
Hash of transaction that includes the ISCC-DECLERATION
0
Output index that includes ISCC-DECLERATION (UTXO based chains)

Mutable Metadata

[{"data": {"name": "Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo", "@type": "ScholarlyArticle", "genre": "journal-article", "author": [{"name": "A. L. Angiolillo", "@type": "Person"}], "@context": "http://schema.org/", "encoding": [{"@type": "MediaObject", "contentUrl": "http://europepmc.org/articles/pmc2192108?pdf=render", "encodingFormat": "application/pdf"}], "publisher": {"name": "Rockefeller University Press", "@type": "Organization"}, "identifier": [{"@type": "PropertyValue", "value": "10.1084/jem.182.1.155", "propertyID": "DOI"}, {"@type": "PropertyValue", "value": "CCc2NpTvjjAt1-CThn8PpupBXcb-CDXdvxRDS65Ls-CR9A7GYULew2C", "propertyID": "ISCC"}], "datePublished": "1995-07-01"}, "schema": "schema.org", "mediatype": "application/ld+json"}]
Close